Bluebird bio Inc [NASDAQ: BLUE] surged by $1.67 during the normal trading session on while it closed the day at $4.98.
Bluebird bio Inc stock has also gained 34.96% of its value over the past 7 days. However, BLUE stock has declined by -22.07% in the 3 months of the year. Over the past six months meanwhile, it has lost -38.62% and lost -40.29% year-on date.
The market cap for BLUE stock reached $48.76 million, with 9.73 million shares outstanding and 9.68 million shares in the current float. Compared to the average trading volume of 462.08K shares, BLUE reached a trading volume of 9347190 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Bluebird bio Inc [BLUE]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BLUE shares is $7.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BLUE stock is a recommendation set at 2.75. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JP Morgan have made an estimate for Bluebird bio Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on February 24, 2025. The new note on the price target was released on November 15, 2024, representing the official price target for Bluebird bio Inc stock. Previously, the target price had yet another drop from $3 to $0.50, while BofA Securities kept a Neutral rating on BLUE stock.
The Average True Range (ATR) for Bluebird bio Inc is set at 0.39, with the Price to Sales ratio for BLUE stock in the period of the last 12 months amounting to 0.58.
BLUE stock trade performance evaluation
Bluebird bio Inc [BLUE] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 34.96. With this latest performance, BLUE shares gained by 4.62% in over the last four-week period, additionally sinking by -38.62% over the last 6 months – not to mention a drop of -76.51% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BLUE stock in for the last two-week period is set at 63.73, with the RSI for the last a single of trading hit 71.32, and the three-weeks RSI is set at 57.94 for Bluebird bio Inc [BLUE]. The present Moving Average for the last 50 days of trading for this stock 4.17, while it was recorded at 3.76 for the last single week of trading, and 8.48 for the last 200 days.
Bluebird bio Inc [BLUE]: An insightful look at the core fundamentals
Bluebird bio Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.28 and a Current Ratio set at 0.48.
Earnings per share (EPS) analysis for Bluebird bio Inc [BLUE] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BLUE. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Bluebird bio Inc go to 36.38%.
Bluebird bio Inc [BLUE]: Institutional Ownership
There are presently around $30.42%, or 30.64%% of BLUE stock, in the hands of institutional investors. The top three institutional holders of BLUE stocks are: BLACKROCK INC. with ownership of 15.44 million shares, which is approximately 0.3986%. VANGUARD GROUP INC, holding 10.3 million shares of the stock with an approximate value of $$10.14 million in BLUE stocks shares; and VANGUARD GROUP INC, currently with $$6.29 million in BLUE stock with ownership which is approximately 0.165%.
